Table 1

Baseline (phase 3) and follow-up (phase 7) characteristics of the 4469 study participants

Baseline (1991–3)Phase 7 (2003–4)
N%/Mean (SD)N%/Mean (SD)
Sex
 Men321772.0
 Women125228.0
Age (years)
 <45119826.8
 45–55216948.5
 ≥55110224.7
 All446949.3 (5.9)
Ethnicity
 White418993.7
 Non-white2806.3
Education
 No or lower secondary196944.1
 A-levels117126.2
 University or higher132929.7
BMI (kg/m2)
 Normal (<25)246355.1171838.4
 Overweight (25–30)166737.3199944.7
 Obese (≥30)3397.675216.8
 All446925.0 (3.5)446926.5 (4.2)
Current smoking
 No400089.5415993.1
 Yes46910.53106.9
Long-standing illness
 No299367.0176739.5
 Yes147633.0270260.5
Total cholesterol concentrations (mmol/l)44696.4 (1.1)44695.7 (1.0)
HDL-cholesterol concentrations (mmol/l)44691.4 (0.4)44691.6 (0.4)
Triglyceride concentrations (mmol/l)44691.3 (0.7)44691.3 (0.7)
LDL-cholesterol concentrations (mmol/l)44694.4 (1.0)44693.5 (0.9)
Lipid-lowering drugs use
 No443599.2398789.2
 Yes340.848210.8
AHEI score, mean (SD)446950.7 (11.9)446951.2 (12.5)
Physical activity (h/week)44693.4 (3.4)44693.7 (3.1)
  • AHEI, alternate healthy eating index; BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein.